Introduction
============

The idea of using the eosinophil count (EC) as a diagnostic marker for clarifying the nature of systemic inflammatory response syndrome (SIRS) belongs to K Abidi, who showed that EC could be used as a diagnostic criterion of sepsis. There are no published data to define the role of dynamic control of EC in the process of intensive therapy as a prognostic marker and indicator of severity condition in critically ill patients. The aim was to determine the informative value of EC in the development of SIRS as a biomarker of sepsis and indicator of the severity condition and prognosis of outcome in the pathological process.

Methods
=======

A total of 143 patients were enrolled in this study who were admitted to the ICU and had SIRS. All patients were divided into a septic group - patients with community-acquired pneumonia, complicated by sepsis - and two SIRS groups of noninfectious genesis - patients who had an acute cerebrovascular accident (CVA) and an acute myocardial infarction (AMI). The absolute EC was measured at admission and in the dynamics on days 3 to 5 of stay.

Results
=======

The median EC was 75 cells/mm^3^in septic patients on admission, which was significantly lower than in patients with CVA (120 cells/mm^3^) and AMI (130 cells/mm^3^). Comparison of EC in septic patients between survivors and those who died showed significant differences (Table [1](#T1){ref-type="table"}). Receiver operating characteristic (ROC) analysis determined a value less than 80 cells/mm^3^as the optimal diagnostic cutoffvalue with a high level of confidence in the comparison of septic and noninfectious groups. Area under the ROC curves was 0.94, sensitivity of 80.8%, specificity of 95.6%, *P*\< 0.0001. There was a significant increase of EC in survivors, while the EC did not change significantly among those who died in the dynamics. ROC analysis determined the cutoff values of EC, which indicated a high risk of an adverse outcome in septic patients (Table [2](#T2){ref-type="table"}).

###### 

Dynamics of eosinophil count depending on outcome in groups.

           EC (cells/mm^3^) at admission   EC (cells/mm^3^) on the 3rd to 5th days                       
  -------- ------------------------------- ----------------------------------------- ------- ----- ----- --------
  Sepsis   100                             50                                        0.006   240   70    0.0004
  CVA      120                             115                                       0.74    150   90    0.001
  AMI      145                             120                                       0.60    195   120   0.017

###### 

Informational value of eosinophil count in assessment of disease outcome.

  Day/Group                AUC    Cutoff (EC, cells/mm^3^)   Sensitivity (%)   Specificity (%)   *P*value
  ------------------------ ------ -------------------------- ----------------- ----------------- ----------
  At admission                                                                                   
     Sepsis                0.83   ≤220                       100               61.5              0.0001
     CVA                   0.53   ≤150                       78.3              37.5              0.743
     AMI                   0.56   ≤190                       85.7              35.7              0.6136
  On the 3rd to 5th days                                                                         
     Sepsis                0.91   ≤120                       92.3              69.2              \<0.0001
     CVA                   0.81   ≤140                       91.3              68.8              \<0.0001
     AMI                   0.75   ≤90                        92.9              46.7              0.0052

Conclusion
==========

EC may be an additional diagnostic marker which characterizes the nature of SIRS. Eosinopenia associated with prognosis of outcome in critical conditions.
